We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Clinical Considerations for the Diagnosis of Endometriosis
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education